Gerrit R. J. Melles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gerrit R. J. Melles has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Silke Oellerich
Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), 1090 Brussels, Belgium
12 shared publications Isabel Dapena
From the Netherlands Institute for Innovative Ocular Surgery (L.v.d.S., I.V., S.O., E.A.G., M.G., A.L., K.V., K.v.D., I.D., G.R.J.M., V.K.), Rotterdam; Melles Cornea Clinic (L.v.d.S., I.V., M.G., A.L., K.V., K.v.D., I.D., G.R.J.M., V.K.), Rotterdam
10 shared publicationsLamis Baydoun
Netherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands
7 shared publicationsKorine van Dijk
From the Netherlands Institute for Innovative Ocular Surgery (L.v.d.S., I.V., S.O., E.A.G., M.G., A.L., K.V., K.v.D., I.D., G.R.J.M., V.K.), Rotterdam; Melles Cornea Clinic (L.v.d.S., I.V., M.G., A.L., K.V., K.v.D., I.D., G.R.J.M., V.K.), Rotterdam
6 shared publicationsRénuka S. Birbal
Netherlands Institute for Innovative Ocular Surgery (NIIOS), Rotterdam, The Netherlands
6 shared publicationsAlina Miron
Affiliations Netherlands Institute for Innovative Ocular Surgery, Rotterdam, The Netherlands, Amnitrans EyeBank Rotterdam, Rotterdam, The Netherlands, Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands
5 shared publications
Latest Publications
- 9 July 2024
- Published by Wolters Kluwer Health in Cornea
- Vol. 44 (4) , 455-462
Clinical Outcomes of Repeat Descemet Membrane Endothelial Keratoplasty After Graft Failure
Purpose: To evaluate the clinical outcomes after repeat Descemet membrane endothelial keratoplasty (DMEK) for technical failure (TF) and secondary graft failure (SGF). Methods: Retrospective analysis of 49 eyes that underwent repeat DMEK either for TF (ie, persistent graft detachment, n = 24) or for SGF (ie, late endothelial graft failure, n = 25). Surgery indications for primary DMEK were Fuchs endothelial corneal dystrophy (FECD, 80%) and bullous keratopathy (BK, 20%). Main outcome measures were best-corrected visual acuity (BCVA), endothelial cell density (ECD), corneal backscattering, pachymetry, and graft survival. Outcomes were compared with an age-matched control group of 49 primary DMEK eyes. Results: Logarithm of the minimum angle of resolution BCVA improved from 0.92 ± 0.6 before to 0.20 ± 0.3 at 1 year after repeat DMEK with better outcomes for eyes with TF than those with SGF (P = 0.046). Donor ECD decreased from 2618 ± 171 cells/mm2 before to 1247 ± 422 cells/mm2 at 1 year postoperatively, with no difference between technical TF and SGF eyes (P > 0.05). One-year BCVA and ECD outcomes were better in the control group than in the repeat DMEK group (P < 0.05). Five-year graft survival probability after repeat DMEK was better for TF than for SGF eyes (100% vs. 75%, P = 0.010) and better for eyes with FECD than BK as primary indication for surgery (92% vs. 65%, P = 0.042). Conclusions: Repeat DMEK gives acceptable clinical outcomes especially when performed for TF in the early period after primary DMEK. Long-term graft survival probability after repeat DMEK is comparable to primary DMEK for FECD eyes, whereas BK eyes may show an elevated risk to develop graft failure again.
- 9 July 2024
- Published by Wolters Kluwer Health in Cornea
- Vol. 44 (4) , 455-462
Clinical Outcomes of Repeat Descemet Membrane Endothelial Keratoplasty After Graft Failure
Purpose: To evaluate the clinical outcomes after repeat Descemet membrane endothelial keratoplasty (DMEK) for technical failure (TF) and secondary graft failure (SGF). Methods: Retrospective analysis of 49 eyes that underwent repeat DMEK either for TF (ie, persistent graft detachment, n = 24) or for SGF (ie, late endothelial graft failure, n = 25). Surgery indications for primary DMEK were Fuchs endothelial corneal dystrophy (FECD, 80%) and bullous keratopathy (BK, 20%). Main outcome measures were best-corrected visual acuity (BCVA), endothelial cell density (ECD), corneal backscattering, pachymetry, and graft survival. Outcomes were compared with an age-matched control group of 49 primary DMEK eyes. Results: Logarithm of the minimum angle of resolution BCVA improved from 0.92 ± 0.6 before to 0.20 ± 0.3 at 1 year after repeat DMEK with better outcomes for eyes with TF than those with SGF (P = 0.046). Donor ECD decreased from 2618 ± 171 cells/mm2 before to 1247 ± 422 cells/mm2 at 1 year postoperatively, with no difference between technical TF and SGF eyes (P > 0.05). One-year BCVA and ECD outcomes were better in the control group than in the repeat DMEK group (P < 0.05). Five-year graft survival probability after repeat DMEK was better for TF than for SGF eyes (100% vs. 75%, P = 0.010) and better for eyes with FECD than BK as primary indication for surgery (92% vs. 65%, P = 0.042). Conclusions: Repeat DMEK gives acceptable clinical outcomes especially when performed for TF in the early period after primary DMEK. Long-term graft survival probability after repeat DMEK is comparable to primary DMEK for FECD eyes, whereas BK eyes may show an elevated risk to develop graft failure again.
- 26 January 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 263, 11-22
How Would Nature See Our Corneal Triumphs? The LXXIX Edward Jackson Lecture
- 26 January 2024
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 263, 11-22
How Would Nature See Our Corneal Triumphs? The LXXIX Edward Jackson Lecture
- 5 November 2023
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 261, 54-65
Bowman Layer Onlay Grafting as a Minimally Invasive Treatment for the Most Challenging Cases in Keratoconus
- 5 November 2023
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 261, 54-65
Bowman Layer Onlay Grafting as a Minimally Invasive Treatment for the Most Challenging Cases in Keratoconus
- Open Access
- 10 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (5) , e0285609
Early and late-onset cell migration from peripheral corneal endothelium
In this study we describe peripheral corneal endothelial cell migration in vitro in the absence and presence of a ROCK-inhibitor. For this study, 21 corneal endothelial graft rims, with attached trabecular meshwork (TM), were prepared from Descemet membrane-endothelial cell sheets by 6.5 mm trepanation. For the initial proof-of-concept, 7 outer graft rims were cultured in a thermo-reversible hydrogel matrix for up to 47 days. To assess the effect of a ROCK-inhibitor, 14 paired outer rims were cultured either with or without ROCK-inhibitor for up to 46 days. At the end of culture, tissue was retrieved from the hydrogel matrix and examined for cell viability and expression of different endothelial cell markers (ZO-1, Na+/K+-ATPase, NCAM, glypican, and vimentin). All cultured rims remained viable and displayed either single regions (n = 5/21) or collective areas (n = 16/21) of cell migration, regardless of the presence or absence of ROCK-inhibition. Migration started after 4±2 days and continued for at least 29 days. The presence of ROCK-inhibitor seemed to contribute to a more regular cell morphology of migrating cells. In addition, 7 outer rims demonstrated a phenotypically distinct late-onset but fast-growing cell population emerging from the area close to the limbus. These cells emerged after 3 weeks of culture and appeared less differentiated compared to other areas of migration. Immunostaining showed that migrated cells maintained the expression patterns of endothelial cell markers. In conclusion, we observed 2 morphologically distinct migrating cell populations with the first type being triggered by a broken physical barrier, which disrupted contact inhibition and the second, late-onset type showing a higher proliferative capacity though appearing less differentiated. This cell subpopulation appeared to be mediated by stimuli other than loss of contact inhibition and ROCK-inhibitor presence. Further exploration of the differences between these cell types may assist in optimizing regenerative treatment options for endothelial diseases.
- 10 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (5) , e0285609
Open AccessEarly and late-onset cell migration from peripheral corneal endothelium
In this study we describe peripheral corneal endothelial cell migration in vitro in the absence and presence of a ROCK-inhibitor. For this study, 21 corneal endothelial graft rims, with attached trabecular meshwork (TM), were prepared from Descemet membrane-endothelial cell sheets by 6.5 mm trepanation. For the initial proof-of-concept, 7 outer graft rims were cultured in a thermo-reversible hydrogel matrix for up to 47 days. To assess the effect of a ROCK-inhibitor, 14 paired outer rims were cultured either with or without ROCK-inhibitor for up to 46 days. At the end of culture, tissue was retrieved from the hydrogel matrix and examined for cell viability and expression of different endothelial cell markers (ZO-1, Na+/K+-ATPase, NCAM, glypican, and vimentin). All cultured rims remained viable and displayed either single regions (n = 5/21) or collective areas (n = 16/21) of cell migration, regardless of the presence or absence of ROCK-inhibition. Migration started after 4±2 days and continued for at least 29 days. The presence of ROCK-inhibitor seemed to contribute to a more regular cell morphology of migrating cells. In addition, 7 outer rims demonstrated a phenotypically distinct late-onset but fast-growing cell population emerging from the area close to the limbus. These cells emerged after 3 weeks of culture and appeared less differentiated compared to other areas of migration. Immunostaining showed that migrated cells maintained the expression patterns of endothelial cell markers. In conclusion, we observed 2 morphologically distinct migrating cell populations with the first type being triggered by a broken physical barrier, which disrupted contact inhibition and the second, late-onset type showing a higher proliferative capacity though appearing less differentiated. This cell subpopulation appeared to be mediated by stimuli other than loss of contact inhibition and ROCK-inhibitor presence. Further exploration of the differences between these cell types may assist in optimizing regenerative treatment options for endothelial diseases.
- Open Access
- 1 January 2023
- Published by Japan Society of Mechanical Engineers in Journal of Advanced Mechanical Design, Systems, and Manufacturing
- Vol. 17 (4) , JAMDSM0047
A portable multifunctional ophthalmic device for remote self-examination of the eye
This paper presents the design of a new portable ophthalmic device, the so-called 3-in-1 device, that allows patients to self-examine their eyes. The device combines the three most essential ophthalmic examinations: slit lamp biomicroscopy to examine the anterior segment of the eye, visual acuity measurement to determine the quality of vision, and non-contact tonometry to assess the intraocular pressure of the eye. The aim of the device is to enable the patient to perform these standard examinations in the comfort of his home and to send the results via the internet to the ophthalmologist for further evaluation. Within the scope of this work, the first prototype of the 3-in-1 device was designed and manufactured. The slit lamp examination procedure can be recorded by a video camera and the footage can be used by an ophthalmologist to check for abnormalities in the anterior chamber of the eye. The visual acuity screener has been designed to be performed under the same conditions as a conventional visual acuity examination by an ophthalmologist. For this function an optical lens system was developed which projects the optotypes to a test distance of 6m. The non-contact tonometer evaluates the degree of deformation of the patient's cornea using machine learning algorithms to draw conclusions about the intraocular pressure. Ultimately, the goal of the device is to improve accessibility to ophthalmic care and the frequency with which examinations are performed in order to detect eye diseases and abnormalities earlier.
- 1 January 2023
- Published by Japan Society of Mechanical Engineers in Journal of Advanced Mechanical Design, Systems, and Manufacturing
- Vol. 17 (4) , JAMDSM0047
Open AccessA portable multifunctional ophthalmic device for remote self-examination of the eye
This paper presents the design of a new portable ophthalmic device, the so-called 3-in-1 device, that allows patients to self-examine their eyes. The device combines the three most essential ophthalmic examinations: slit lamp biomicroscopy to examine the anterior segment of the eye, visual acuity measurement to determine the quality of vision, and non-contact tonometry to assess the intraocular pressure of the eye. The aim of the device is to enable the patient to perform these standard examinations in the comfort of his home and to send the results via the internet to the ophthalmologist for further evaluation. Within the scope of this work, the first prototype of the 3-in-1 device was designed and manufactured. The slit lamp examination procedure can be recorded by a video camera and the footage can be used by an ophthalmologist to check for abnormalities in the anterior chamber of the eye. The visual acuity screener has been designed to be performed under the same conditions as a conventional visual acuity examination by an ophthalmologist. For this function an optical lens system was developed which projects the optotypes to a test distance of 6m. The non-contact tonometer evaluates the degree of deformation of the patient's cornea using machine learning algorithms to draw conclusions about the intraocular pressure. Ultimately, the goal of the device is to improve accessibility to ophthalmic care and the frequency with which examinations are performed in order to detect eye diseases and abnormalities earlier.
- Open Access
- 1 December 2021
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 51 (6) , 381-392
Evolving Techniques and Indications of Descemet Membrane Endothelial Keratoplasty
Endothelial keratoplasty has replaced traditional penetrating keratoplasty for the treatment of corneal endothelial dysfunction. It offers faster, more predictable, stable visual recovery and low rejection rates while the surgery itself is less invasive. Descemet membrane endothelial keratoplasty (DMEK) is currently the gold standard for the treatment of Fuchs endothelial dystrophy, bullous keratopathy, and corneal edema after cataract surgery. Its favorable long-term outcomes are increasingly reported by large study groups. This review summarizes the current literature on new DMEK techniques, including size and shape modifications, new graft delivery techniques, and surgical pearls for challenging cases like eyes with glaucoma, glaucoma tubes, and failed penetrating keratoplasties.
- 1 December 2021
- Published by Galenos Yayinevi in Turkish Journal of Ophthalmology
- Vol. 51 (6) , 381-392
Open AccessEvolving Techniques and Indications of Descemet Membrane Endothelial Keratoplasty
Endothelial keratoplasty has replaced traditional penetrating keratoplasty for the treatment of corneal endothelial dysfunction. It offers faster, more predictable, stable visual recovery and low rejection rates while the surgery itself is less invasive. Descemet membrane endothelial keratoplasty (DMEK) is currently the gold standard for the treatment of Fuchs endothelial dystrophy, bullous keratopathy, and corneal edema after cataract surgery. Its favorable long-term outcomes are increasingly reported by large study groups. This review summarizes the current literature on new DMEK techniques, including size and shape modifications, new graft delivery techniques, and surgical pearls for challenging cases like eyes with glaucoma, glaucoma tubes, and failed penetrating keratoplasties.
- 14 October 2021
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (5) , E1186
Misconceptions in DMEK surgery
- 14 October 2021
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (5) , E1186
Misconceptions in DMEK surgery
- Open Access
- 4 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0246516
Preclinical testing of small diameter Descemet membrane endothelial keratoplasty grafts to increase tissue availability
In this study, we describe a process of preparing, surgically manipulating, and validating a novel “small diameter” 4mm circular Descemet membrane endothelial keratoplasty (DMEK) graftin vitro. Three small diameter DMEK grafts can be prepared from a single donor endothelium and could, therefore, potentially expand the donor pool. Prior to clinical use, however, we aimed to examine each step of the process to determine the effect on the endothelial cell loss and whether or not cells retained their capacity to migrate uniformly. For this study, circular small diameter grafts, obtained from twelve corneas of ten donors deemed ineligible for transplantation, were included. Small diameter DMEK graft preparation was successful in all cases (n = 36). Endothelial cell density (ECD), determined in the eye bank on seventeen grafts, showed an average decrease from 2413 (±189) cells/mm2before to 2240 (±413) cells/mm2after preparation. Twenty-four grafts were used to simulate DMEK-surgeryin vitroand were successfully stained with 0.06% trypan blue, loaded into a straight DMEK-injector, unfolded, positioned, and centered within the circular ~ 4mm descemetorhexis. The estimated % area populated by viable cells on the grafts decreased from on average 92 (±3) % before to 78 (±10) % (n = 4) afterin vitrosurgery. Cells displayed a capacity for uniform cell migration from all edges of the graft (n = 4) when embedded in the 3D hydrogel system. Our data show, that by using anin vitromodel of DMEK-surgery it was possible to test the 4mm circular DMEK grafts from eye bank preparation to surgical implantation. The cell loss afterin vitrosurgery was comparable with thein vivoECD decline early after DMEK and the capacity of the cells to migrate to potentially cover bare stroma indicates that these small diameter grafts may be a viable clinical option to treat central endothelial disease.
- 4 February 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (2) , e0246516
Open AccessPreclinical testing of small diameter Descemet membrane endothelial keratoplasty grafts to increase tissue availability
In this study, we describe a process of preparing, surgically manipulating, and validating a novel “small diameter” 4mm circular Descemet membrane endothelial keratoplasty (DMEK) graftin vitro. Three small diameter DMEK grafts can be prepared from a single donor endothelium and could, therefore, potentially expand the donor pool. Prior to clinical use, however, we aimed to examine each step of the process to determine the effect on the endothelial cell loss and whether or not cells retained their capacity to migrate uniformly. For this study, circular small diameter grafts, obtained from twelve corneas of ten donors deemed ineligible for transplantation, were included. Small diameter DMEK graft preparation was successful in all cases (n = 36). Endothelial cell density (ECD), determined in the eye bank on seventeen grafts, showed an average decrease from 2413 (±189) cells/mm2before to 2240 (±413) cells/mm2after preparation. Twenty-four grafts were used to simulate DMEK-surgeryin vitroand were successfully stained with 0.06% trypan blue, loaded into a straight DMEK-injector, unfolded, positioned, and centered within the circular ~ 4mm descemetorhexis. The estimated % area populated by viable cells on the grafts decreased from on average 92 (±3) % before to 78 (±10) % (n = 4) afterin vitrosurgery. Cells displayed a capacity for uniform cell migration from all edges of the graft (n = 4) when embedded in the 3D hydrogel system. Our data show, that by using anin vitromodel of DMEK-surgery it was possible to test the 4mm circular DMEK grafts from eye bank preparation to surgical implantation. The cell loss afterin vitrosurgery was comparable with thein vivoECD decline early after DMEK and the capacity of the cells to migrate to potentially cover bare stroma indicates that these small diameter grafts may be a viable clinical option to treat central endothelial disease.
- 24 December 2020
- Published by Wiley in Acta Ophthalmologica
- Vol. 99 (7) , 712-729
New developments in corneal endothelial cell replacement
Corneal transplantation is currently the most effective treatment to restore corneal clarity in patients with endothelial disorders. Endothelial transplantation, either by Descemet membrane endothelial keratoplasty (DMEK) or by Descemet stripping (automated) endothelial keratoplasty (DS(A)EK), is a surgical approach that replaces diseased Descemet membrane and endothelium with tissue from a healthy donor eye. Its application, however, is limited by the availability of healthy donor tissue. To increase the pool of endothelial grafts, research has focused on developing new treatment options as alternatives to conventional corneal transplantation. These treatment options can be considered as either ‘surgery‐based’, that is tissue‐efficient modifications of the current techniques (e.g. Descemet stripping only (DSO)/Descemetorhexis without endothelial keratoplasty (DWEK) and Quarter‐DMEK), or ‘cell‐based’ approaches, which rely on in vitro expansion of human corneal endothelial cells (hCEC) (i.e. cultured corneal endothelial cell sheet transplantation and cell injection). In this review, we will focus on the most recent developments in the field of the ‘cell‐based’ approaches. Starting with the description of aspects involved in the isolation of hCEC from donor tissue, we then describe the different natural and bioengineered carriers currently used in endothelial cell sheet transplantation, and finally, we discuss the current ‘state of the art’ in novel therapeutic approaches such as endothelial cell injection.
- 24 December 2020
- Published by Wiley in Acta Ophthalmologica
- Vol. 99 (7) , 712-729
New developments in corneal endothelial cell replacement
Corneal transplantation is currently the most effective treatment to restore corneal clarity in patients with endothelial disorders. Endothelial transplantation, either by Descemet membrane endothelial keratoplasty (DMEK) or by Descemet stripping (automated) endothelial keratoplasty (DS(A)EK), is a surgical approach that replaces diseased Descemet membrane and endothelium with tissue from a healthy donor eye. Its application, however, is limited by the availability of healthy donor tissue. To increase the pool of endothelial grafts, research has focused on developing new treatment options as alternatives to conventional corneal transplantation. These treatment options can be considered as either ‘surgery‐based’, that is tissue‐efficient modifications of the current techniques (e.g. Descemet stripping only (DSO)/Descemetorhexis without endothelial keratoplasty (DWEK) and Quarter‐DMEK), or ‘cell‐based’ approaches, which rely on in vitro expansion of human corneal endothelial cells (hCEC) (i.e. cultured corneal endothelial cell sheet transplantation and cell injection). In this review, we will focus on the most recent developments in the field of the ‘cell‐based’ approaches. Starting with the description of aspects involved in the isolation of hCEC from donor tissue, we then describe the different natural and bioengineered carriers currently used in endothelial cell sheet transplantation, and finally, we discuss the current ‘state of the art’ in novel therapeutic approaches such as endothelial cell injection.
- 14 August 2020
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 21 (4) , 615-623
The influence of preparation and storage time on endothelial cells in Quarter–Descemet membrane endothelial keratoplasty (Quarter–DMEK) grafts in vitro
Quarter–Descemet membrane endothelial keratoplasty (Quarter-DMEK) has been introduced as a modification of the standard DMEK technique to increase the pool of endothelial grafts. In this study, we evaluated in vitro changes in endothelial cell distribution, viability and morphology of Quarter–DMEK grafts when stored in organ-culture medium. Quarter–DMEK grafts were prepared from 5 corneas and stored in organ-culture medium for 4, 7 and 11 days. Endothelial cell re-distribution was investigated by light microscopy, cell viability by a Calcein-AM assay, and expression of endothelial and non-endothelial markers by immunohistochemistry. Three standard DMEK-grafts were used as controls. After preparation, all Quarter–DMEK grafts showed a band with no viable endothelial cells along the radial cut graft edges [average width 190 (± 20) µm]. Endothelial cell density in the central graft area decreased by 12%, 23% and 26% after 4, 7, and 11 days of storage, respectively. At the same time, empty bands along the cut edges were re-populated and some cells migrated to the stromal side of the Descemet membrane (DM). These cells showed an altered phenotype, as indicated by expression of migration marker CD73 and fibroblast marker αSMA. Majority of migration occurred within the first 4 days of storage. Our data suggest that endothelial cells on Quarter–DMEK grafts re-distribute during organ-culture storage to re-populate preparation-induced empty bands and after re-distribution, cells may show further migration to the stromal DM side during storage.
- 14 August 2020
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 21 (4) , 615-623
The influence of preparation and storage time on endothelial cells in Quarter–Descemet membrane endothelial keratoplasty (Quarter–DMEK) grafts in vitro
Quarter–Descemet membrane endothelial keratoplasty (Quarter-DMEK) has been introduced as a modification of the standard DMEK technique to increase the pool of endothelial grafts. In this study, we evaluated in vitro changes in endothelial cell distribution, viability and morphology of Quarter–DMEK grafts when stored in organ-culture medium. Quarter–DMEK grafts were prepared from 5 corneas and stored in organ-culture medium for 4, 7 and 11 days. Endothelial cell re-distribution was investigated by light microscopy, cell viability by a Calcein-AM assay, and expression of endothelial and non-endothelial markers by immunohistochemistry. Three standard DMEK-grafts were used as controls. After preparation, all Quarter–DMEK grafts showed a band with no viable endothelial cells along the radial cut graft edges [average width 190 (± 20) µm]. Endothelial cell density in the central graft area decreased by 12%, 23% and 26% after 4, 7, and 11 days of storage, respectively. At the same time, empty bands along the cut edges were re-populated and some cells migrated to the stromal side of the Descemet membrane (DM). These cells showed an altered phenotype, as indicated by expression of migration marker CD73 and fibroblast marker αSMA. Majority of migration occurred within the first 4 days of storage. Our data suggest that endothelial cells on Quarter–DMEK grafts re-distribute during organ-culture storage to re-populate preparation-induced empty bands and after re-distribution, cells may show further migration to the stromal DM side during storage.